About Saints Capital
Saints Capital is a company based in Denver (United States). It operates as a B2B. Saints Capital has completed 3 acquisitions, including Acsis, Laureate Pharma and Merisel.
- Headquarter Denver, United States
-
Sectors
Financial Services
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Acsis
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Saints Capital
Detailed funding history for Saints Capital
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Saints Capital
Saints Capital has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Acsis, Laureate Pharma and Merisel.
Investment portfolio details for Saints Capital
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Offers cloud-based supply chain asset tracking solutions
|
Locked | Locked | 1996 | Locked | |
|
Provides biopharmaceutical development, manufacturing, and contract services for pharmaceutical companies.
|
Locked | Locked | 1981 | Locked | |
|
Visual marketing solutions are provided to premier brands and retailers.
|
Locked | Locked | 1980 | Locked |
Complete acquisition details for Saints Capital
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Saints Capital
Detailed financials for Saints Capital
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Saints Capital Comparisons
Peer comparison for Saints Capital
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Saints Capital
Detailed competitors of Saints Capital
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Saints Capital
Complete news archive for Saints Capital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saints Capital
Saints Capital is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
Investments are managed by Saints Capital, an investment firm based in Denver, United States, specializing in the direct secondary market. Shares of private companies are purchased from general partners, limited partners in venture capital and private equity funds, founders, employees, and institutional investors. Structured transactions are offered, including loans, deferred payments, and upside sharing arrangements. The portfolio includes companies in healthcare, technology, energy, retail, and business services sectors.
Saints Capital has made 3 acquisitions, including Acsis, Laureate Pharma, and Merisel.